Metastatic Squamous Neck Cancer With Occult Primary
2 clinical trials · Condition
◉ Watch Metastatic Squamous Neck Cancer With Occult Primary
| Record | Firm | Date |
|---|---|---|
| Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer (NCT00397384) | National Cancer Institute (NCI) | 2007-01-01 |
| Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer (NCT00098631) | National Cancer Institute (NCI) | 2004-10-01 |
Track Metastatic Squamous Neck Cancer With Occult Primary automatically
Every clearance here is in the API, with alerts when new ones post.